Full-Time

Senior Manager

HR Project Management, Corp Functions

Posted on 9/11/2026

Deadline 9/21/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$82.9k - $199.1k/yr

+ Bonus + Commission + Short-term incentive + Equity award

Company Historically Provides H1B Sponsorship

Woonsocket, RI, USA

Hybrid

Bachelor's

Category
Project & Program Management (1)
Required Skills
Data Analysis

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • At least 7 years of work experience.
  • At least 5 years of Human Resources experience.
  • At least 2 years of project management experience, including planning, coordination, execution, and follow-through.
  • Strong strategic planning and organizational skills, with the ability to translate priorities into structured execution.
  • Strong problem-solving and decision-making skills.
  • Strong collaboration, stakeholder management, and influencing skills.
  • Strong written and verbal communication skills, including the ability to prepare clear executive-ready materials.
  • Strong business acumen and ability to connect workstreams to broader functional and business priorities.
  • Strong judgment, organization, and attention to detail in a complex environment.
  • Ability to manage multiple priorities, remove barriers, and keep work moving with a high level of ownership and accountability.
  • Demonstrated emotional intelligence and ability to build trust across a broad set of partners.
Responsibilities
  • Partner with the Chief People Officer of Corporate Functions, Programs Lead, and Corporate Functions Human Resources leaders to drive execution of strategic priorities across the leadership team.
  • Translate strategic objectives into actionable plans, timelines, and coordinated follow-through across key initiatives.
  • Support alignment across leadership team priorities, ensuring initiatives, decisions, and resources are coordinated in service of business and colleague needs.
  • Manage the operating rhythm for the leadership team, including management processes, meeting cadence, agenda planning, and follow-up on actions and decisions.
  • Coordinate planning, execution, and implementation of high-impact projects and key initiatives across the function.
  • Build structure and visibility around strategic priorities through project plans, milestone tracking, governance, and progress updates.
  • Support leaders in identifying risks, escalating barriers, and maintaining momentum across multiple workstreams.
  • Use project management tools, data analysis, and stakeholder feedback to provide insights that support prioritization and decision-making.
  • Coordinate and at times lead department-level initiatives that advance functional priorities and improve organizational effectiveness.
  • Drive process improvements, manage workflows, and support efficiency and effectiveness in day-to-day operations.
  • Support internal messaging and communications planning to reinforce priorities and create clarity across stakeholders.
  • Prepare briefing materials, updates, and executive-ready content that support leadership discussions and action planning.
  • Build relationships across stakeholders, using sound judgment, emotional intelligence, and influencing skills to support collaboration and delivery.
  • Execute assigned projects while communicating effectively with stakeholders at all levels of the organization.
Desired Qualifications
  • Bachelor’s degree or specialized training or relevant professional qualification.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS Caremark settled FTC probes July 14, 2026, reducing legal overhang.
  • CVS expanded Eli Lilly weight-loss access in early fourth quarter 2026.

What critics are saying

  • Louisiana's February 2026 $45 million settlement keeps PBM reform pressure on Caremark margins.
  • Aetna paid $117.7 million on March 11, 2026 for Medicare coding fraud allegations.
  • Federal and state antitrust actions threaten a Caremark-Aetna breakup by 2027.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across 87 million PBM members.
  • CVS combines retail, insurance, and PBM data under one operating system.
  • CVS launched Google Cloud partnerships and AI tools across claims, service, and engagement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 28th, 2026
CVS stock down 12% in a month despite 34% annual gain, faces 2027 headwinds

CVS Health stock has declined 12.3% over the past month, sitting about 15% below its 52-week high, though it remains up 34% over the trailing twelve months. The company's revenue reached approximately $415 billion, up 7.4% year-over-year. Management raised its full-year 2026 adjusted earnings per share guidance by $0.60 to a range of $7.90 to $8.10. For 2027, the company anticipates membership declines at Caremark and continued 340B programme pressure, offset by Aetna's recovery, which added over $2 billion in adjusted operating income in the first half of 2026. Management considers a 2027 adjusted EPS outlook of at least $8.44 reasonable. Historically, CVS has experienced varied recovery periods following market downturns, with some rebounds taking years rather than months.

Yahoo Finance
Aug 25th, 2026
CVS and Roche stocks could benefit from expanding GLP-1 drug market

CVS Health and Roche could benefit from the growing GLP-1 drug market, alongside current leaders Eli Lilly and Novo Nordisk. CVS Health has improved its financial performance, with second-quarter revenue rising 7.3% year-over-year to $106.1 billion and adjusted earnings per share increasing 42.5% to $2.58. The pharmacy chain offers all approved GLP-1 medicines in the US, including Eli Lilly's Zepbound and Foundayo, plus Novo Nordisk's Wegovy. CVS also provides low-cost online consultations at $29 to assess patient eligibility for GLP-1 drugs. Beyond GLP-1 initiatives, CVS is addressing previous business challenges and is positioned to capitalise on rising healthcare spending in the US over the next decade.

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.